| Data |
Ora |
Fonte |
Titolo |
|---|
| 03/2/2025 | 15:05 | PRNUS | Azitra, Inc. to Present at the BIO CEO & Investor Conference |
| 27/1/2025 | 22:05 | PRNUS | Azitra, Inc. to Present at The Microcap Conference |
| 16/1/2025 | 20:12 | EDGAR2 | Form 8-K - Current report |
| 16/1/2025 | 16:36 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 15/1/2025 | 14:30 | PRNUS | Azitra Announces Pricing of $1.5 Million Public Offering of.. |
| 14/1/2025 | 23:23 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 14/1/2025 | 22:12 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
| 14/1/2025 | 22:10 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
| 14/1/2025 | 22:05 | PRNUS | Azitra Announces Proposed Public Offering of Common Stock |
| 26/11/2024 | 22:05 | EDGAR2 | Form 8-K - Current report |
| 12/11/2024 | 23:05 | PRNUS | Azitra, Inc. Announces Q3 2024 Financial Results and.. |
| 12/11/2024 | 23:01 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 29/10/2024 | 14:00 | BW | Azitra to Present at BIO-Europe 2024 |
| 11/10/2024 | 15:00 | BW | Azitra to Participate in the 2024 Maxim Healthcare Virtual.. |
| 09/10/2024 | 23:01 | EDGAR2 | Form ARS - Annual Report to Security Holders |
| 09/10/2024 | 22:55 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
| 24/9/2024 | 14:00 | BW | Azitra, Inc. Announces Late-Breaking Presentation at the.. |
| 18/9/2024 | 15:00 | BW | Azitra Receives Fast Track Designation for ATR-04 for Skin.. |
| 16/9/2024 | 23:47 | EDGAR2 | Form 144 - Report of proposed sale of securities |
| 06/9/2024 | 22:30 | BW | Azitra to Present at the H.C. Wainwright 26th Annual Global.. |
| 28/8/2024 | 14:30 | BW | Azitra Announces First Patient Dosed in Phase 1b Trial of.. |
| 22/8/2024 | 15:00 | BW | Azitra Receives Study May Proceed letter from the FDA for.. |
| 20/8/2024 | 22:15 | BW | Azitra Announces First Patient Screened and Scheduled to.. |
| 13/8/2024 | 00:23 | BW | Azitra, Inc. Announces Q2 2024 Financial Results and.. |
| 12/8/2024 | 23:15 | EDGAR2 | Form 8-K - Current report |
| 12/8/2024 | 23:02 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 02/8/2024 | 22:05 | EDGAR2 | Form SC 13D/A - General Statement of Acquisition of.. |
| 29/7/2024 | 22:01 | EDGAR2 | Form SC 13G - Statement of Beneficial Ownership by Certain.. |
| 26/7/2024 | 22:05 | EDGAR2 | Form 8-K - Current report |
| 25/7/2024 | 23:57 | BW | CORRECTING and REPLACING Azitra, Inc. Announces Closing of.. |
| 25/7/2024 | 20:15 | BW | Azitra, Inc. Announces Closing of Public Offering |
| 25/7/2024 | 12:03 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 24/7/2024 | 03:20 | BW | Azitra, Inc. Announces Pricing of $10.0 Million Public.. |
| 23/7/2024 | 14:00 | BW | Azitra, Inc. Strengthens Global Intellectual Property.. |
| 19/7/2024 | 23:27 | EDGAR2 | Form S-1/A - General form for registration of securities.. |
| 15/7/2024 | 23:11 | EDGAR2 | Form FWP - Filing under Securities Act Rules 163/433 of free.. |
| 15/7/2024 | 12:21 | EDGAR2 | Form S-1 - General form for registration of securities under.. |
| 27/6/2024 | 22:05 | BW | Azitra, Inc. Announces Reverse Stock Split |
| 03/6/2024 | 22:30 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
| 31/5/2024 | 14:00 | BW | Azitra, Inc. Announces Presentation at the 2024 BIO.. |
| 24/5/2024 | 22:55 | EDGAR2 | Form PRE 14A - Other preliminary proxy statements |
| 17/5/2024 | 14:00 | BW | Azitra, Inc. Announces Positive Preclinical Data from ATR-04.. |
| 10/5/2024 | 14:00 | BW | Azitra, Inc. Announces Positive Preclinical Data of ATR-12.. |
| 09/5/2024 | 23:05 | EDGAR2 | Form 8-K - Current report |
| 09/5/2024 | 23:03 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 09/5/2024 | 23:00 | BW | Azitra, Inc. Announces Q1 2024 Financial Results and.. |
| 22/4/2024 | 22:30 | BW | Azitra, Inc. Announces New Preclinical Data to be Presented.. |
| 18/4/2024 | 22:15 | BW | Azitra, Inc. to Present New Data at Three Upcoming.. |
| 15/3/2024 | 21:15 | BW | Azitra, Inc. Announces Full Year 2023 Financial Results and.. |
| 26/2/2024 | 22:10 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
